This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: David V Weber: Innovator in Protein Purification
Introduction
David V Weber is a notable inventor based in Nutley, NJ (US), recognized for his contributions to the field of protein purification. With a total of 2 patents, he has made significant advancements in the methods used to purify interleukin-2 (IL-2) and related proteins.
Latest Patents
Weber's latest patents focus on innovative methods for the purification of interleukin-2. One patent details the purification of IL-2 from various sources, including synthetic mixtures and culture mediums conditioned by natural IL-2 producing cells. The methods utilize IL-2 receptor-affinity adsorbents, which immobilize soluble IL-2 receptors on solid supports. This approach allows for the production of highly purified IL-2 in a single step, significantly reducing the presence of aggregated forms often found in other purification methods. Another patent addresses the purification of chimeric proteins containing an IL-2 moiety, employing similar techniques to ensure high purity and efficiency.
Career Highlights
David V Weber is currently associated with Hoffmann-La Roche Inc., where he continues to innovate in the field of biochemistry and protein purification. His work has been instrumental in advancing methodologies that enhance the quality and yield of therapeutic proteins.
Collaborations
Throughout his career, Weber has collaborated with esteemed colleagues, including Pascal Sebastian Bailon and John E Smart. These partnerships have contributed to the development of cutting-edge purification techniques and have fostered a collaborative environment for scientific advancement.
Conclusion
David V Weber's contributions to the field of protein purification, particularly through his patents on interleukin-2, highlight his role as a significant innovator. His work not only enhances the efficiency of protein purification but also paves the way for advancements in therapeutic applications.
